ArticleVaccines2022

Effectiveness of the BNT162b2 mRNA Vaccine Compared with Hybrid Immunity in Populations Prioritized and Non-Prioritized for COVID-19 Vaccination in 2021-2022: A Naturalistic Case-Control Study in Sweden.

Armin Spreco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.